GlassScriptPhysician profile
Charles Andrew Hogan
NPI 1689968729
$2,339.31
in general payments reported to CMS, 2019-2025
28 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $68.12 · 2021: $26.87 · 2022: $1,084 · 2023: $284 · 2024: $401 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $880.15 | 2022 | |
| Medtronic USA, INC. | $168.26 | 2019 | |
| Next Science LLC | $148.22 | 2025 | Blastx, Xperience |
| Abbvie INC. | $141.46 | 2023-2024 | |
| Highridge Medical LLC | $136.50 | 2024 | Mobi-C Plug & Fit US |
| Dexcom, INC. | $101.31 | 2021-2023 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $101.17 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $91.56 | 2023-2024 | Freestyle Libre 3 |
| Medtronic, INC. | $86.79 | 2025 | Stealthstation S8 Platform, Aquamantys(Tm) |
| Otsuka America Pharmaceutical, INC. | $69.91 | 2020-2024 | Rexulti |
| Horizon Therapeutics Plc | $41.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $36.79 | 2023-2024 | Farxiga, Airsupra |
| Brainlab, INC. | $31.96 | 2025 | Brainlab, INC. |
| Lilly USA, LLC | $29.44 | 2024 | Jardiance, Zepbound |
| Solventum Corporation | $27.29 | 2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $26.60 | 2022 | |
| Nevro Corp. | $24.09 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.28 | 2022 | |
| Sanofi Pasteur INC. | $21.05 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.98 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.88 | 2023 | |
| Orthofix Medical, INC. | $17.20 | 2024 | Shoreline Asc |
| Azurity Pharmaceuticals, INC. | $17.00 | 2024 | Horizant |
| Glaxosmithkline, LLC. | $16.67 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $16.38 | 2023 | Xarelto |
| Exact Sciences Corporation | $16.11 | 2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $15.49 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.